New research finds 87% of medtechs lack consistent methods to share product information across global regulatory teams

Growing regulatory complexity driving need for a single source of regulatory information pleasanton, calif. , nov. 15, 2023 /prnewswire/ -- most medtech companies (87%) can't seamlessly exchange product information between in-country and global regulatory assurance teams, according to the 2023 regulatory benchmark report from veeva medtech.
VEEV Ratings Summary
VEEV Quant Ranking